UBS Group’s Escalon Medical Corp ESMC Stock Holding History

UBS Group’s Portfolio ESMC Stock Details ESMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-706	Closed	–	–	8382
2016 Q3	$0	Sell	706 -888	-56%	-$642	﹤0.01%	8229
2016 Q2	$1K	Buy	1,594 +900	+130%	+$692	﹤0.01%	7634
2016 Q1	$1K	Buy	+694	New	+$642	﹤0.01%	7533
2015 Q4	–	Sell	-2,709	Closed	-$3K	–	8791
2015 Q3	$3K	Sell	2,709 -774	-22%	-$1K	﹤0.01%	8010
2015 Q2	$5K	Buy	3,483 +1,167	+50%	+$1.62K	﹤0.01%	7917
2015 Q1	$3K	Sell	2,316 -2,065	-47%	-$2.99K	﹤0.01%	8387
2014 Q4	$7K	Buy	+4,381	New	+$6.26K	﹤0.01%	8758

Other funds holding ESMC

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

UBS Group's ESMC Position: Q4 2016 in Review

UBS Group sold out of Escalon Medical Corp (ESMC) in Q4 2016, closing a stake of 706 shares.

UBS Group first reported a position in ESMC in Q4 2014 and held it in 7 quarters. The position peaked at $7K in Q4 2014. 3 funds tracked by Wall St. Rank hold ESMC as of Q4 2016.

UBS Group reported no remaining Escalon Medical Corp position as of Q4 2016 after selling out during the quarter.
UBS Group sold 706 Escalon Medical Corp shares in Q4 2016.
UBS Group first reported a position in Escalon Medical Corp in Q4 2014 and held it in 7 quarters.
UBS Group's Escalon Medical Corp position peaked at $7K in Q4 2014.
3 funds tracked by Wall St. Rank held Escalon Medical Corp as of Q4 2016.

Based on UBS Group's 13F filing for Q4 2016, filed 14 Feb 2017.